<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Guide to pregabalin (Lyrica) for chronic pain - uses, dosing, side effects, and effectiveness for neuropathic pain and fibromyalgia.">
    <meta name="keywords" content="pregabalin, Lyrica, nerve pain medication, fibromyalgia medication, neuropathic pain">
    <title>Pregabalin (Lyrica) | ChronicSoreness</title>
    <link rel="stylesheet" href="../css/styles.css">
</head>
<body>
    <header class="header"><nav class="nav-container"><div class="logo"><a href="../index.html"><span class="logo-icon">ðŸ’œ</span><span class="logo-text"><strong>Chronic</strong>Soreness</span></a></div><button class="mobile-menu-toggle" aria-label="Toggle menu"><span class="hamburger"></span></button><ul class="nav-menu"><li><a href="../conditions.html">Conditions</a></li><li><a href="../treatments.html">Treatments</a></li><li><a href="../medications.html">Medications</a></li><li><a href="../exercise.html">Exercise</a></li><li><a href="../nutrition.html">Nutrition</a></li><li><a href="../mental-health.html">Mental Health</a></li></ul></nav></header>
    <main id="main-content">
        <article class="page-header"><h1>Pregabalin (Lyrica)</h1><p>A medication for neuropathic pain and fibromyalgia</p></article>
        <section class="content-section">
            <div class="container">
                <h2>What Is Pregabalin?</h2>
                <p>Pregabalin (brand name Lyrica) is an anticonvulsant medication FDA-approved for several chronic pain conditions. It's chemically related to gabapentin but has more predictable absorption and can be dosed twice daily.<sup>1</sup></p>

                <h2>FDA-Approved Pain Uses</h2>
                <ul>
                    <li>Diabetic peripheral neuropathy</li>
                    <li>Postherpetic neuralgia</li>
                    <li>Fibromyalgia</li>
                    <li>Spinal cord injury-related pain</li>
                </ul>

                <h2>How It Works</h2>
                <ul>
                    <li>Binds to calcium channels in nervous system</li>
                    <li>Reduces release of excitatory neurotransmitters</li>
                    <li>Decreases abnormal nerve signaling</li>
                </ul>

                <h2>Dosing</h2>
                <ul>
                    <li>Starting: 75mg twice daily or 50mg three times daily</li>
                    <li>Typical: 150-300mg daily in divided doses</li>
                    <li>Maximum: 600mg daily</li>
                    <li>Adjust for kidney function</li>
                </ul>

                <h2>Side Effects<sup>2</sup></h2>
                <ul>
                    <li>Dizziness and drowsiness</li>
                    <li>Weight gain</li>
                    <li>Peripheral edema (swelling)</li>
                    <li>Blurred vision</li>
                    <li>Difficulty concentrating</li>
                    <li>Dry mouth</li>
                </ul>

                <h2>Warnings</h2>
                <ul>
                    <li>Controlled substance (Schedule V)</li>
                    <li>Don't stop suddenly - taper</li>
                    <li>Avoid alcohol</li>
                    <li>May affect driving</li>
                    <li>Monitor for mood changes</li>
                </ul>

                <h2>Effectiveness<sup>3</sup></h2>
                <p>About 30-50% of people achieve meaningful pain relief. Works best for neuropathic pain conditions.</p>

                <h2>References</h2>
                <ol>
                    <li>Derry S, Bell RF, Straube S, et al. Pregabalin for neuropathic pain in adults. <em>Cochrane Database Syst Rev</em>. 2019;1(1):CD007076.</li>
                    <li>Zaccara G, Gangemi P, Perucca P, Specchio L. The adverse event profile of pregabalin: a systematic review and meta-analysis. <em>Eur J Clin Pharmacol</em>. 2011;67(8):723-733.</li>
                    <li>Moore RA, Straube S, Wiffen PJ, et al. Pregabalin for acute and chronic pain in adults. <em>Cochrane Database Syst Rev</em>. 2009;(3):CD007076.</li>
                </ol>
            </div>
        </section>
    </main>
    <footer class="footer"><div class="container"><p class="disclaimer">The information provided is for educational purposes only and is not medical advice.</p><p class="copyright">Â© 2024 ChronicSoreness. All rights reserved.</p></div></footer>
    <script src="../js/main.js"></script>
</body>
</html>
